For Health Professionals
FDA Expert Commentary and Interview Series on Medscape
As part of the continuing collaboration between FDA and Medscape 
, a series of interviews and commentaries are available to communicate important safety information to clinicians. Featuring FDA experts, these original commentaries cover a wide range of topics related to FDA's multi-faceted mission of protecting and promoting the public health by ensuring the safety and quality of medical products such as drugs, foods, and medical devices.
The complete terms and framework of the partnership with Medscape are described in the Memorandum of Understanding.
Interviews
Quinine and Leg Cramps: Not Worth the Risk Featuring Hala H. Shamsuddin, MD, Medical Officer, Office Of Antimicrobial Products, FDA Center for Drug Evaluation and Research October 2012 | |
The New Opioid REMS: The FDA View Featuring Gerald J. Dal Pan, MD, MHS, Director, Office of Surveillance and Epidemiology, FDA Center for Drug Evaluation and Research. September 2012 | |
At-Home Rapid HIV Testing: An Interview With FDA Featuring Elliot Cowan, PhD, Chief, Product Review Branch, Division of Emerging and Transfusion Transmitted Diseases, FDA Center for Biologics Evaluation and Research July 2012 | |
| Statins: The Story Behind the Label Changes Featuring Amy Egan, MD, MPH, Deputy Director for Safety, March 2012 |
| Simvastatin 80 mg: An FDA Expert Interview Featuring Amy Egan, MD, MPH, Deputy Director for Safety, August 2011 |
| Ticagrelor: The View From the FDA Featuring Norman Stockbridge, MD, PhD, Director, July 2011 |
 | The Changes in Sunscreen Labeling Featuring Reynold Tan, PhD, Interdisciplinary Scientist, July 2011 |
Video Programs
 | FDA Drug Safety Communications: http://www.medscape.com/viewarticle/767477 Featuring Dr. Gregory Busse, Team Lead for Drug Safety Communication in the FDA Center for Drug Evaluation and Research July 2012 |
 | A Short Tutorial on REMS: The FDA Perspective Featuring Dr. Gerald Dal Pan, Acting Director, FDA Office of Surveillance and Epidemiology in the Center for Drug Evaluation and Research April 2012 |
 | Repairing Pelvic Organ Prolapse: What's Best? Featuring Dr. Diane Mitchell, Assistant Director for Science for FDAs Center for Devices and Radiological Health |
 | What To Do About Misleading Drug Ads Featuring Michael Sauers, Team Leader for FDAs Office of Prescription Drug Promotion in the Center for Drug Evaluation and Research. |
 | The Problem With Drug Shortages Featuring Jouhayna Saliba, PharmD, Senior Regulatory Program Manager for FDA's Drug Shortage Program in the Center for Drug Evaluation and Research. |
 | Current and Future State of Drug-Eluting Stents Featuring Ashley Boam, BSE, MSBE, Chief of FDA's Interventional Cardiology Devices Branch, and Andrew Farb, MD, Medical Officer and Senior Reviewer in the Interventional Cardiology Devices Branch October 2011 |
 | Surgical Fires: How They Start and How to Prevent Them Featuring Stephanie Joseph, FDA Biomedical Engineer, Center for Devices and Radiological Health and Dr. Kenneth Silverstein, Chair, Department of Anesthesiology and Medical Director, Perioperative Services at Christiana Care Health System October 2011 |
| FDA Commissioner: "Safety Science" Key to Drug Regulation Featuring Dr. Margaret Hamburg, Commissioner of the FDA February 2011 |
| Food Recalls: FDA Takes Preventive Approach Featuring Michael Taylor, FDA Deputy Commissioner for Foods February 2011 |
| Safe Use of Drugs Requires Reports From Clinicians Karen Weiss, MD, MPH, Program Director for the FDA's Safe Use Initiative February 2011 |
| Are You Prescribing Unapproved Drugs? Charles E. Lee, MD, Medical Officer in the Office of Compliance March 2011 |
Continuing Education Programs
